Négociation Faes Farma, S.A. - FAE CFD

Faes Farma, S.A., a pharmaceutical company, develops, produces and commercializes pharmaceutical products and raw materials primarily in Spain and Portugal. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Colme to treat chronic alcoholism; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. In addition, it offers sitagliptine, and sitagliptine and metformine products to treat diabetes type-II; Hidroferol; Acoxxel; Diosmin and Micronized Diosmin for chronic venous insufficiency; Sulbutiamine to treat asthenia, concentration, and memory deficit; Arginine Aspartate; and swine feeding products. It also exports its products approximately to 60 countries. Faes Farma, S.A. was founded in 1933 and is headquartered in Madrid, Spain.